TRUMENBA

ਉਤਪਾਦ ਝਲਕ

About TRUMENBA

TRUMENBA is a vaccine designed to protect against invasive meningococcal disease caused by Neisseria meningitidis serogroup B. It is a recombinant lipoprotein vaccine that contains two components: Neisseria meningitidis serogroup B recombinant lipoprotein 2086 subfamily B and Neisseria meningitidis serogroup B recombinant lipoprotein 2086 subfamily A.

Key Benefits & Uses

• Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B
• Protection against meningococcal meningitis and septicemia
• Recommended for individuals 10 through 25 years of age

Active Ingredient & Action

The active ingredients in TRUMENBA stimulate the body's immune system to produce antibodies against the Neisseria meningitidis serogroup B bacteria. These antibodies help to prevent the bacteria from causing invasive meningococcal disease.

Important Notes

TRUMENBA should be administered in a series of two doses, with the second dose given at least 6 months after the first dose. It is essential to follow the recommended vaccination schedule to ensure optimal protection against invasive meningococcal disease. As with any vaccine, TRUMENBA may cause side effects such as pain, redness, or swelling at the injection site, as well as fever or fatigue. If you experience any severe side effects or have concerns, consult your healthcare provider.